Henry Fuchs

President, Worldwide Research and Development

Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Biomarin Pharmaceutical Inc (BMRN)	Former President, Worldwide Research & Development	$838,731	—	$5,120,600	$1,541,239	$602,030	$25,256	$8,127,856
2023	Biomarin Pharmaceutical Inc (BMRN)	Former President, Worldwide Research & Development	$818,269	—	$6,792,991	$1,456,102	$563,063	$30,393	$9,660,818
2022	Biomarin Pharmaceutical Inc (BMRN)	Former President, Worldwide Research & Development	$782,308	—	$6,063,957	$1,152,293	$680,388	$25,508	$8,704,454
2021	Biomarin Pharmaceutical Inc (BMRN)	President, Worldwide R&D	$750,000	—	$4,202,276	$1,202,572	$755,600	$18,918	$6,929,366
2020	Biomarin Pharmaceutical Inc (BMRN)	President, Worldwide R&D	$769,231	—	$4,732,826	$1,385,520	$536,250	$32,748	$7,456,575
2019	Biomarin Pharmaceutical Inc (BMRN)	President, Worldwide R&D	$695,192	—	$4,275,463	$1,189,277	$828,000	$29,567	$7,017,499
2018	Biomarin Pharmaceutical Inc (BMRN)	President, Worldwide R&D	$668,269	—	$2,680,926	$1,716,498	$687,925	$24,111	$5,777,729
2017	Biomarin Pharmaceutical Inc (BMRN)	President, Worldwide R&D	$637,231	—	$3,460,084	$2,335,264	$590,720	$22,125	$7,045,424

Executive changes

Retired his current role at Biomarin Pharmaceutical Inc (BMRN)
2025-03-03

Earnings-call appearances

Biomarin Pharmaceutical Inc Q1 FY2024 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-04-24
Biomarin Pharmaceutical Inc Q4 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2024-02-22
Biomarin Pharmaceutical Inc Q3 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-11-01
Biomarin Pharmaceutical Inc Q2 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-07-31
Biomarin Pharmaceutical Inc Q1 FY2023 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2023-04-26
Biomarin Pharmaceutical Inc Q3 FY2022 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2022-10-26
Biomarin Pharmaceutical Inc Q3 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2020-11-05
Biomarin Pharmaceutical Inc Q2 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2020-08-04
Biomarin Pharmaceutical Inc Q1 FY2020 Earnings Call
Biomarin Pharmaceutical Inc (BMRN)

2020-04-29